日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world genomic landscape of colon and rectal cancer

结肠癌和直肠癌的真实基因组图谱

Schulze, Markus; Wang, XiaoZhe; Hamad, Jawad; Quintanilha, Julia C F; Pasquina, Lincoln W; Hopkins, Julia F; Scheuenpflug, Juergen; Feng, Zheng

Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib

伴有组织细胞增生和脾酪氨酸激酶融合的髓系肿瘤对福斯他替尼有反应

Risch, Zachary; Kaffenberger, Benjamin H; Chung, Catherine G; Samorodnitsky, Eric; Hoskins, Emily L; Dao, Thuy; Smith, Amy; Wall, Sarah A; Brammer, Jonathan; Reeser, Julie W; Wing, Michele R; Hopkins, Julia F; Albacker, Lee A; Abruzzo, Lynne V; Eisele, Caprice D; Freud, Aharon G; Roychowdhury, Sameek; Walsh, Katherine E

Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status

对携带种系 BRCA1/2 突变的早期三阴性乳腺癌患者进行新辅助他拉唑帕尼治疗:探索肿瘤 BRCA 突变状态

Telli, Melinda L; Litton, Jennifer K; Beck, J Thaddeus; Jones, Jason M; Andersen, Jay; Mina, Lida A; Brig, Raymond; Danso, Michael; Yuan, Yuan; Symmans, William F; Hopkins, Julia F; Albacker, Lee A; Abbattista, Antonello; Noonan, Kay; Mata, Marielena; Laird, A Douglas; Blum, Joanne L

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

HER2 突变的计算和功能分析揭示了变构激活机制和改变的药理效应

Ishiyama Noboru, O'Connor Matthew, Salomatov Andrei, Romashko Darlene, Thakur Shalabh, Mentes Ahmet, Hopkins Julia F, Frampton Garrett M, Albacker Lee A, Kohlmann Anna, Roberts Christopher, Buck Elizabeth

Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study

ABRAZO 研究中接受 talazoparib 治疗的 gBRCA1/2 突变携带者晚期乳腺癌肿瘤的基因组分析

Turner, Nicholas C; Laird, A Douglas; Telli, Melinda L; Rugo, Hope S; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A; Balmaña, Judith; Fasching, Peter A; Hurvitz, Sara A; Hopkins, Julia F; Albacker, Lee A; Chelliserry, Jijumon; Chen, Ying; Conte, Umberto; Wardley, Andrew M; Robson, Mark E

HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma

HRAS突变定义了头颈部鳞状细胞癌的一个独特亚组

Coleman, Niamh; Marcelo, Kathrina L; Hopkins, Julia F; Khan, Nusrat Israr; Du, Robyn; Hong, Lingzhi; Park, Edward; Balsara, Binaifer; Leoni, Mollie; Pickering, Curtis; Myers, Jeffrey; Heymach, John; Albacker, Lee A; Hong, David; Gillison, Maura; Le, Xiuning

Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations

泛癌中程序性死亡配体-1和程序性死亡配体-2结构变异的图谱

Hoskins, Emily L; Samorodnitsky, Eric; Wing, Michele R; Reeser, Julie W; Hopkins, Julia F; Murugesan, Karthikeyan; Kuang, Zheng; Vella, Raven; Stein, Leah; Risch, Zachary; Yu, Lianbo; Adebola, Serifat; Paruchuri, Anoosha; Carpten, John; Chahoud, Jad; Edge, Stephen; Kolesar, Jill; McCarter, Martin; Nepple, Kenneth G; Reilley, Matthew; Scaife, Courtney; Tripathi, Abhishek; Single, Nancy; Huang, Richard S P; Albacker, Lee A; Roychowdhury, Sameek

A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres

端粒含量的泛癌图谱显示,RAD21和HGF的改变与更长的端粒相关。

Sharaf, Radwa; Montesion, Meagan; Hopkins, Julia F; Song, Jiarong; Frampton, Garrett M; Albacker, Lee A

Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer

HER2阴性、携带BRCA1/2种系突变的乳腺癌患者对Talazoparib治疗反应的决定因素

Blum, Joanne L; Laird, A Douglas; Litton, Jennifer K; Rugo, Hope S; Ettl, Johannes; Hurvitz, Sara A; Martin, Miguel; Roché, Henri H; Lee, Kyung-Hun; Goodwin, Annabel; Chen, Ying; Lanzalone, Silvana; Chelliserry, Jijumon; Czibere, Akos; Hopkins, Julia F; Albacker, Lee A; Mina, Lida A

TreeTuner: A pipeline for minimizing redundancy and complexity in large phylogenetic datasets

TreeTuner:一种用于最大限度减少大型系统发育数据集中的冗余和复杂性的流程

Zhang, Xi; Hu, Yining; Eme, Laura; Maruyama, Shinichiro; Eveleigh, Robert J M; Curtis, Bruce A; Sibbald, Shannon J; Hopkins, Julia F; Filloramo, Gina V; van Wijk, Klaas J; Archibald, John M